/ 06 · Capsule six · Examinable counselling

OSCE & communication. Counselling as a competency.

Communication in regenerative medicine is usually treated as a soft skill. The platform treats it as an examinable competency — structured into stations, marked against a scheme, and certified at three levels. This capsule defines how a partner clinic teaches, examines, and certifies the counselling skill that holds the whole pathway together.

/ 01The explanation framework

Four layers, one mechanism. Same biology, different reader.

A single sentence about SVF must work at four different registers depending on who is reading it. The patient in the consultation room needs simple, embodied language. The consent form needs informed, medico-legally accurate language. The colleague-to-colleague exchange needs precise clinical language. The athletic patient with a competitive calendar needs a fourth register that handles the timeline pressure that the other three do not.

The four-layer framework is not a translation exercise. The mechanism described in each layer is identical — SVF as a heterogeneous cell pool acting on the local tissue environment. What changes is the vocabulary, the depth, and the emotional contract between speaker and reader. A clinician who can move between the four layers without losing the underlying biology is the clinician the platform certifies.

The cards below show the four layers applied to the same single clinical claim: that SVF modulates the joint environment rather than regrowing cartilage. The same claim appears four times in four registers. A staff member's fluency across the four is the core OSCE competency that the rest of this capsule examines.

/ LAYER 01
Simple
For the conversation
"Your knee is irritated, and the tissue inside has stopped behaving well. We take cells from your own body that calm down inflammation and help blood vessels grow. We put them in your knee. They don't replace the cushion — they tell your knee to behave better."
/ LAYER 02
Informed
For the consent form
"Autologous adipose-derived SVF, prepared by minimal manipulation at point of care, is delivered intra-articularly to modulate the local inflammatory and trophic environment. The procedure does not regenerate articular cartilage. Evidence supports clinically meaningful improvement in KL II and KL III knees over 6 to 12 months."
/ LAYER 03
Clinical
For the colleague
"Heterogeneous cell pool from lipoaspirate, ≥ 5 × 10⁶ viable nucleated cells per knee, ultrasound-guided. Mechanism is paracrine modulation: angiogenic, anti-inflammatory, trophic. KL II–III, neutral alignment, conservative care failed. Primary endpoint VAS at 6 months, registry capture from day one."
/ LAYER 04
Athletic
For the patient with a calendar
"The cells signal repair, but the tissue takes weeks to remodel. We can plan your return to training around your next event, but the date is set by the tissue, not by the calendar. If your event is sooner than the biology supports, we are not doing the right procedure today."
/ 02OSCE stations

Four stations. Each timed. Each marked.

The four stations below each correspond to one of the four layers of the framework. A staff member rotates through all four in a single examination cycle. The stations are designed to be run by an internal examiner using the marking scheme on the right of each card. Each station has a single primary objective, a clear pass criterion, and a defined time limit. The pass mark is on each station independently; failing one station does not invalidate the others.

/ Station 01
Patient-facing explanationThe 90-second account
8 min
Total
/ Scenario & task

A standardised patient presents to the clinic for a first consultation about SVF for KL III knee osteoarthritis. They have a vague understanding that SVF is "stem cell therapy" and expect cartilage regrowth. The candidate has 90 seconds to deliver the layer-one explanation, then five minutes to take questions and recover any misunderstanding before the bell.

The examiner is silent for the first 90 seconds. The standardised patient may interrupt with one open question and one challenging follow-up, drawn from a station-specific script.

Failure mode: the candidate slips into clinical vocabulary, makes a structural-restoration claim, or breaks the 90-second envelope.

/ Marking scheme
  • Used layer-one register throughout/ 3
  • Avoided "stem cell" as a clinical claim/ 2
  • Stated that cartilage is not regrown/ 3
  • Named at least one mechanism (angiogenic, anti-inflammatory, trophic)/ 2
  • Took at least one patient question without slipping register/ 3
  • Checked patient understanding before closing/ 2
  • PASS ≥ 10 of 15/ 15
/ Station 02
Consent conversationThe informed register
10 min
Total
/ Scenario & task

The same standardised patient returns two weeks later, having decided to proceed. The candidate is asked to walk the patient through the consent, covering mechanism, expected timeline, alternatives, risks, and explicit acknowledgement that the procedure is not a cartilage-regrowth therapy. The candidate must document, on a single-page form, that each consent element has been discussed.

Failure mode: the candidate reads the form aloud without translation, misses an alternative therapy, or accepts a signature on a form where understanding has not been checked.

/ Marking scheme
  • Covered all five consent elements (mechanism, timeline, alternatives, risks, structural claim)/ 5
  • Translated each element from form to conversation/ 3
  • Named PRP, BMAC, and arthroplasty as alternatives/ 2
  • Checked understanding before signature/ 3
  • Documented the conversation on the form/ 2
  • PASS ≥ 11 of 15/ 15
/ Station 03
Colleague hand-offThe clinical register
5 min
Total
/ Scenario & task

The candidate has 90 seconds to brief a senior colleague (the examiner) on a patient who has just completed an SVF procedure for knee OA. The hand-off must include cell dose, image confirmation, indication and selection rationale, registry status, and follow-up schedule. The examiner then has three minutes to ask two clinical questions drawn from a station-specific script.

Failure mode: the candidate descends into patient-facing language, omits cell dose or registry status, or cannot defend the selection rationale.

/ Marking scheme
  • Stated cell dose and viability/ 2
  • Stated image-confirmation status/ 2
  • Stated KL grade and selection rationale/ 3
  • Stated registry capture status/ 2
  • Stated follow-up schedule/ 2
  • Answered two clinical questions with precision/ 4
  • PASS ≥ 11 of 15/ 15
/ Station 04
The athletic patientThe calendar conversation
10 min
Total
/ Scenario & task

The standardised patient is a competitive recreational athlete with chronic Achilles tendinopathy. They have a marathon in twelve weeks. They want SVF and they want to run the race. The candidate must handle the calendar conversation — honour the athlete's goal, respect the biology, and arrive at a shared decision that either defers the race, defers the procedure, or proceeds with a structured plan and explicit expectation about race-day performance.

Failure mode: the candidate either capitulates to the athlete's timeline or refuses the conversation outright. Both end badly.

/ Marking scheme
  • Used layer-four register throughout/ 3
  • Stated that the calendar does not set the date/ 3
  • Offered three pathway options (defer race, defer procedure, proceed with managed expectation)/ 3
  • Did not capitulate to timeline pressure/ 3
  • Arrived at a documented shared decision/ 3
  • PASS ≥ 11 of 15/ 15
"Counselling is not a soft skill. It is the examinable competency on which every other clinical decision in the pathway depends."
/ 03Viva question bank

Six questions. Six defended answers.

A viva, in the medical education sense, is a structured oral examination on a single clinical topic. The bank below contains six representative viva questions drawn from the four clinical capsules, with the answer the platform expects a certified staff member to give. The bank is illustrative rather than exhaustive; the full bank is part of the platform deliverable to partners and runs to several dozen questions per clinical capsule.

/ FUNDAMENTALS
Tell me what SVF actually is, in one sentence, without using the word "stem".
A heterogeneous pool of cells extracted from adipose tissue, including adipose-derived progenitors, endothelial precursors, pericytes, and immune-modulating cells, prepared by minimal manipulation at point of care. The pool, not any single cell, does the work.
/ KNEE
A patient is KL IV bone-on-bone. What do you say to them?
That SVF is not the right tool for their disease stage and that the honest answer is a surgical consultation for joint replacement. Offering SVF here would be selling hope, not medicine. The conversation is the same length whether the answer is yes or no.
/ SPINE
Why does the platform not offer SVF for radicular pain?
Because the mechanism does not fit the problem. Radicular pain is mechanical nerve-root compression. SVF acts through paracrine modulation of the tissue environment. Decompression, not regenerative signalling, is the appropriate intervention. The wrong tool for the right problem is the wrong tool.
/ SPORTS
An athlete has an acute hamstring strain and wants SVF. What do you say?
That SVF is not an acute-injury therapy. The native healing response handles the acute strain given appropriate rehabilitation. If a chronic or recurrent pattern develops at the same site over the coming months, the SVF conversation becomes appropriate. Acute strain is a rehabilitation question, not a regenerative one.
/ BUSINESS
A patient asks if SVF is FDA approved. How do you answer?
By distinguishing the regulatory frame. SVF prepared by minimal manipulation at point of care is positioned within the FDA's homologous use framework rather than as an approved drug. Approved is not the right word; "regulated tissue" is the right phrase. A printed information sheet is offered for a deeper read.
/ OSCE
A patient says "my friend got stem cells and it cured her knee". What do you say?
Acknowledge the friend's experience without contradicting it, then re-frame: every regenerative procedure is a different cell preparation, different indication, different patient. The platform's intervention is described on its own evidence, not on anyone else's anecdote. The friend's story is information, not a prescription.
/ 04Safe-phrase library

What not to say. What to say instead.

The safe-phrase library is a comparative reference. Each row shows a sentence that staff frequently slip into, which damages the patient relationship or the platform's regulatory positioning, alongside the sentence the platform recommends as the substitute. The library is not a script. It is a discipline of vocabulary that protects the procedure, the patient, and the partner.

Do not say
"This will regrow your cartilage."
Structural claim that is not supported.
Say instead
"This signals your knee to behave better. It does not regrow the cushion."
Mechanism-honest, expectation-honest.
Do not say
"We use stem cells to fix the damage."
"Stem cells" is a marketing term, not a regulatory one.
Say instead
"We use a mix of cells from your own body that calms inflammation and improves the local biology."
Accurate, compositionally precise, regulatorily defensible.
Do not say
"You'll be back to running in three weeks."
Calendar-driven promise the biology cannot keep.
Say instead
"The tissue takes weeks to remodel. We will plan your return around the tissue, not the calendar."
Biology-led timeline, shared decision-ready.
Do not say
"It works for everyone who has it done."
Untrue, and forecloses the unsuccessful-outcome conversation later.
Say instead
"About half of patients in your category report meaningful improvement at one year. About a third report some improvement. About one in six report none."
Honest envelope, survives the twelve-month call.
Do not say
"The FDA approves this."
Regulatorily inaccurate and exposes both staff and clinic.
Say instead
"This is regulated as a tissue, not a drug. The framework is different from an approved medication."
Precise, defensible, opens the explanation rather than closing it.
Do not say
"This is the latest, most advanced treatment."
Promotional, undermines clinical credibility.
Say instead
"This is one option among several. Whether it is right for you depends on your imaging, your goals, and what you have already tried."
Patient-centred, sets the selection conversation up cleanly.
/ 05Difficult conversations

Three conversations that destroy practices. Three scripts that protect them.

A small number of predictable conversations account for a disproportionate share of patient dissatisfaction, complaints, and reputation damage in regenerative practices. The platform addresses the three highest-frequency conversations directly. Each is structured into an opening, a turn, and a close, with notes on what the conversation must accomplish and what failure modes to avoid.

/ Conversation 01
The patient who does not meet criteria
/ The script

"Thank you for coming in. I have looked carefully at your imaging and your history, and I owe you an honest answer. Based on what I see, SVF is not the right procedure for you at this point."

"This is not because anything is wrong with you. It is because the evidence for SVF is strongest in a specific group, and you are not currently in that group. I want to walk you through what that group looks like and what your options are."

"My recommendation is [specific alternative pathway]. If your situation changes — if conservative care produces a different picture, or if your imaging changes — we can revisit this conversation. The door is not closed. It is just not the right door for today."

/ What the script must do

Honour the patient's effort to be there. They have travelled, paid, and prepared. Acknowledge that before the decline.

Refuse the procedure without refusing the patient. The "no" is to the procedure today. The relationship continues.

Offer a specific alternative. A vague "try something else" feels like dismissal. A named alternative pathway is a real referral.

Document the conversation. The "not today" recommendation goes in the chart with the reasoning. This protects the staff, the clinic, and the patient if they later ask why.

Failure modes: capitulating and offering SVF anyway, dismissing the patient brusquely, or leaving the door so wide open that the patient believes the criteria will change next week.

/ Conversation 02
The patient with unrealistic expectations
/ The script

"Before we go any further, I want to make sure we are talking about the same thing. Tell me what you understand SVF will do for your knee."

"I can hear what you are hoping for, and I understand why. Let me share what the procedure actually does. It signals your knee to calm inflammation and to repair where it can. It does not regrow the cartilage. It does not turn the clock back. The benefit, when it comes, is gradual and it is partial."

"Now that I have said that, I want to ask: knowing what the procedure actually does, is it still something you want to consider? There is no wrong answer."

/ What the script must do

Surface the expectation before the procedure. An expectation discovered at month six cannot be corrected; an expectation discovered at week zero can.

Honour the hope. The patient is not unreasonable for hoping. They are responding to years of marketing language about regenerative medicine.

Replace the expectation with a real one. "Gradual and partial" is the substitute that survives the twelve-month call.

Re-open the decision. Once the expectation has been adjusted, the consent conversation effectively restarts. Some patients will then choose not to proceed, which is a successful outcome of the conversation.

Failure modes: proceeding without surfacing the expectation, lecturing the patient rather than checking their understanding, or implying the patient was foolish for hoping.

/ Conversation 03
The non-responder at twelve months
/ The script

"I want to thank you for coming back for your one-year review. I know this is not the conversation either of us hoped to have. Your scores are showing that you have not had the response we were aiming for, and I want to talk about what that means and what we do next."

"This is part of what we discussed at the start. We expected most patients in your category to respond, some partially, and some not at all. You are in the group that has not responded. That is a real outcome, not a failure of effort on either of our sides."

"My recommendations from here are [specific next steps]. We will continue to follow you in the registry. The information from your case helps us select better for future patients. If there is anything you want to say about how this has felt, I want to hear it."

/ What the script must do

Name the outcome directly. Euphemisms make non-response feel like failure or evasion. Plain language is respectful.

Reference the original conversation. The one-in-six envelope discussed at consent makes this conversation expected rather than catastrophic.

Refuse the blame on either side. The patient did not fail. The clinician did not fail. The biology did not respond.

Offer a forward path. Even if SVF is over, the clinical relationship is not. A next step preserves the relationship and the clinic's reputation.

Invite the patient to speak. The non-responder often has unspoken disappointment that, voiced, drains away. Unvoiced, it becomes a review, a complaint, or a story they tell others.

Failure modes: avoiding the patient, suggesting that another procedure will fix it without strong evidence, or implying the patient did something wrong.

/ 06Certification

Three levels. Three scopes of practice.

The platform's certification model is a three-tier structure that maps to the role a staff member plays in the patient pathway. Each tier corresponds to a defined set of OSCE stations passed at the threshold scores above. A partner clinic deploying the platform uses the certification model to define which staff member can hold which conversation with which patient at which stage. The tiers are not seniority levels. They are scopes of practice within the regenerative pathway.

/ TIER 01

Conversation-certifiedLayer 01 only

May conduct the first-contact patient-facing conversation under supervision. Hands off to a higher-tier colleague before consent. Typically front-of-house clinical staff and physiotherapy assistants.
/ TIER 02

Consent-certifiedLayers 01 — 02

May independently conduct the consent conversation, document it, and obtain signature. Typically clinical nursing staff, allied health professionals, and physician assistants.
/ TIER 03

Procedure-certifiedAll four layers

May own the full pathway: selection, procedure, follow-up, and the difficult conversations. Required for the proceduralist and for any staff handling the non-responder review at twelve months.
"A regenerative practice is only as strong as its weakest conversation. The certification model defines who is allowed to have which conversation."
/ 07What's next

The last capsule. The engine beneath the platform.

Six capsules have now defined the platform's clinical content, business architecture, and counselling competency. The seventh and final capsule is the technical engine that runs beneath all of them. It describes the data models, the rules-based decision support, the registry schema, and the integration patterns that let the platform plug into a partner organisation's existing clinical and commercial systems. It is the capsule that turns a clinical document into a deployable software layer.

/ 07 · FINAL CAPSULE
DeveloperThe clinical engine
Python data models, the rules-based suitability engine, the registry schema, the integration patterns. The technical substrate that runs beneath the clinical surface, and the layer that closes the circle from biology to deployment.
Read capsule →